Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121907) titled 'Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in Australia' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Caranx Medical
Condition:
TAVI(Transcatheter Aortic Valve Implantation)
Intervention:
Device: TAVR using a guidance software
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 15, 2025
Target Sample Size: 10
To know more, visit https...